Physician profile
Joellen Vanzander
NPI 1881819019
$933.70
in general payments reported to CMS, 2019-2025
10 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2021: $159 · 2023: $96.30 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.92 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $218.89 | 2025 | Zoryve |
| Pfizer INC. | $196.24 | 2019-2023 | |
| Galderma Laboratories, L.P. | $139.46 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $123.24 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $98.17 | 2019 | |
| Almirall LLC | $57.11 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $45.00 | 2019 | |
| Biofrontera INC. | $25.90 | 2019 | |
| Sandoz INC. | $17.85 | 2019 | |
| Leo Pharma INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joellen Vanzander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.